AstraZeneca PLC (AZN) stock
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca profit margin
Profit margin (net margin) is net income as a percentage of revenue.
For fiscal 2025 it was 17.4%, against 13.0% the year before. The highest annual figure on record is 17.4% in fiscal 2025.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 17.4% | +4.4 |
| FY2024 | Dec 31, 2024 | 13.0% | +0.0 |
| FY2023 | Dec 31, 2023 | 13.0% | +5.6 |
| FY2022 | Dec 31, 2022 | 7.4% | +7.1 |
| FY2021 | Dec 31, 2021 | 0.3% | −11.7 |
| FY2020 | Dec 31, 2020 | 12.0% | +6.5 |
| FY2019 | Dec 31, 2019 | 5.5% | −4.3 |
| FY2018 | Dec 31, 2018 | 9.8% | −3.6 |
| FY2017 | Dec 31, 2017 | 13.4% | −1.9 |
| FY2016 | Dec 31, 2016 | 15.2% | +3.8 |
| FY2015 | Dec 31, 2015 | 11.4% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 16.3% | +13.0 |
| Q2 FY2025 | Jun 30, 2025 | 16.9% | +10.3 |
| Q2 FY2024 | Jun 30, 2024 | 14.9% | +2.8 |
| Q2 FY2023 | Jun 30, 2023 | 15.9% | +13.7 |
| Q2 FY2022 | Jun 30, 2022 | 3.3% | −3.4 |
| Q2 FY2021 | Jun 30, 2021 | 6.7% | −3.0 |
| Q2 FY2020 | Jun 30, 2020 | 12.0% | – |
| Q2 FY2019 | Jun 30, 2019 | 2.2% | – |
| Q2 FY2018 | Jun 30, 2018 | 6.8% | – |
| Q2 FY2017 | Jun 30, 2017 | 9.7% | – |
See a number that looks wrong?